EchoPixel, Inc.

EchoPixel, Inc. develops advanced medical imaging technology, focusing on creating interactive 4D holograms that enhance understanding of complex anatomical relationships, improving surgical planning and intra-operative guidance for healthcare professionals. Founded in 2012 by Sergio Aguirre, EchoPixel, Inc. is headquartered in Mountain View, US.

The company specializes in advanced medical imaging, having secured a Series A funding round led by Intel Capital in October 2017, raising USD 8. 5 mn. EchoPixel has completed a total of 5 deals to date, with its latest funding supporting its ongoing growth and technology development. EchoPixel, Inc.

specializes in advanced medical imaging technology, providing a software platform that facilitates the creation of a 4D interactive hologram, known as True3D. This innovative solution enables healthcare professionals to utilize a digital twin of patients constructed from standard medical images, thus enhancing the comprehension of complex 3D anatomical relationships. The platform is designed to improve surgical planning and intra-operative guidance, especially in structural heart and congenital heart procedures, effectively addressing the limitations posed by traditional 2D and 2. 5D imaging.

EchoPixel primarily serves world-leading hospitals and healthcare institutions, leveraging its technology to enhance patient care and promote minimally invasive therapeutic approaches. The company's geographic reach encompasses major markets, including the United States and select regions in Europe, where it aims to transform the delivery of patient care through precision health. EchoPixel generates revenue through the licensing of its True3D platform to healthcare providers, primarily through a direct-to-consumer model within the B2B sector. The company engages clients through structured agreements that may involve one-time licensing fees, ongoing maintenance, and support as part of its service offerings.

Transactions typically occur as hospitals integrate the True3D system into their surgical workflows, allowing physicians to utilize the technology for patient-specific surgical planning and guidance. This integration enhances procedure efficiency and safety, further reinforcing the value proposition of EchoPixel's offerings. While specific pricing plans for the platform are proprietary, the business model emphasizes partnerships with healthcare institutions that seek to leverage cutting-edge imaging technology to improve surgical outcomes. In October 2017, EchoPixel, Inc.

raised USD 8. 5 mn in a Series A financing round led by Intel Capital, with support from investors including Binomial Ventures and Lam Research Corporation. The funding is expected to assist in the development and launch of new products aimed at advancing their imaging technology. EchoPixel plans to expand its market presence into additional regions in Europe by 2025, leveraging the recent funding to enhance product offerings and support further adoption of its True3D platform in surgical settings.